Geneva, May 4 -- International Clinical Trials Registry received information related to the study (KCT0011902) titled 'An Exploratory Study of Nicergoline (Sermion(R)) for Dizziness in Patients Aged 65 and Older' on April 24.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
Primary Sponsor: Asan Medical Center
Condition:
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Intervention:
Drug : -Investigational product: Sermion(R) 10 mg (Nicergoline 10 mg)
-Number of participants: Total of 50 subjects
-Dosage and administration: Oral administration, three times daily, before meals
-Treatment duration: 90...